Menstrual-Cycle Phase Training: What the New Strength Study Found

The headline claim needs an audit before it becomes training advice.

Claim	Did this trial test it?
Concentrating lower-body volume in the follicular phase beats balanced training	Yes; no significant advantage was detected
Concentrating volume in the luteal phase beats balanced training	Yes; no significant advantage was detected
Symptoms never affect training readiness	No
Hormonal contraception or irregular cycles produce the same result	No
Symptom-guided autoregulation is ineffective	No; it was not tested

The 2026 randomized trial addressed planned phase-based volume distribution in healthy participants with eumenorrheic cycles. It did not evaluate every practice described as “cycle-aware training.”

What was actually tested

The Medicine & Science in Sports & Exercise trial included 24 healthy eumenorrheic females and ran across three consecutive menstrual cycles. The mean duration was 12.2 weeks, with a standard deviation of 1.3 weeks.

Researchers used a randomized unilateral design. Rather than comparing only separate groups of people, the assignments involved individual legs and participants, helping create within-participant comparisons while limiting training to the tested lower-body model. The design produced four conditions:

• a non-exercising control;
• continuous exercise with volume balanced across both phases;
• high volume in the follicular phase and low volume in the luteal phase;
• low volume in the follicular phase and high volume in the luteal phase.

“High” and “low” had concrete meanings. High volume was five sets per exercise twice weekly, amounting to at least 10 sets per muscle each week. Low volume was one set per exercise twice weekly, or no more than five sets per muscle per week. This was therefore a test of concentrating a meaningful difference in set volume, not merely changing exercise names on a calendar.

The primary outcome was thigh lean mass measured with dual-energy X-ray absorptiometry. Secondary measures included vastus lateralis cross-sectional area, leg fat-free mass measured by bioelectrical impedance analysis, one-repetition-maximum strength, and maximal voluntary isometric contraction.

How the unilateral comparison changes the reading

Researchers used a randomized unilateral design, with leg and participant assignments producing the four conditions. This helps compare trained and untrained tissue while reducing some between-person variation. It also means the experiment did not reproduce the systemic fatigue, time demands, or coordination of a whole-body program.

The design is strong for the narrow question and narrow for broader ones. Three menstrual cycles are enough to observe adaptations, but not to establish what happens over years of phase-based programming.

What the result supports

All resistance-training conditions gained more than the non-exercising control in thigh lean mass, vastus lateralis cross-sectional area, leg fat-free mass, and 1RM strength. Those training-versus-control findings were reported at p<.001. The direct comparisons among balanced training, follicular-heavy training, and luteal-heavy training found no significant differences, with all p-values at or above .17.

The journal record therefore supports two statements at once. Resistance training caused measurable adaptations in this sample, and redistributing the tested volume toward one menstrual-cycle phase did not improve those adaptations relative to distributing it continuously.

This is not the same as saying the three schedules were proven perfectly equal. A non-significant difference means the trial did not detect a clear separation under its design and sample size. With 24 participants and a roughly three-cycle intervention, smaller differences would be difficult to estimate precisely. The practical conclusion is that the study provides no evidence that either phase-concentrated schedule was superior—not that all conceivable effects have been ruled out.

The authors reported that volume-load, rather than menstrual-cycle phase-based training, was associated with several adaptations. That detail aligns with the pattern in the trial: the muscles exposed to resistance training improved relative to control, while changing when high and low volumes occurred did not create a detectable advantage among training conditions.

Volume still needs careful interpretation. Five sets twice weekly was the study's high-volume condition, while one set twice weekly was its low-volume condition. Those definitions belong to this intervention, these exercises, and these participants. They are not universal boundaries between “enough” and “not enough.” The separate dose-response analysis explains why population-level volume relationships cannot select one person's ideal set number.

Symptom-guided changes remain a different question

Online discussion often merges two ideas: prescribing volume from cycle phase alone and adjusting training in response to symptoms. This trial tested the first. It did not test symptom-guided autoregulation.

That distinction prevents an overcorrection. The findings weigh against claiming that healthy lifters need a follicular-heavy or luteal-heavy volume schedule to gain muscle or strength. They do not justify dismissing an individual's reported symptoms. Day-to-day autoregulation based on readiness, performance, and comfort is a broader practice than the fixed high/low phase schedules tested here.

Nor should the result be generalized automatically to people using hormonal contraception, those with irregular cycles, or those with medical conditions. The population was specifically described as healthy and eumenorrheic. Questions about persistent or severe symptoms belong with a qualified healthcare professional, not an internet training template.

For the population and program studied, no significant disadvantage was detected for balanced resistance training, and neither phase-concentrated schedule showed an advantage. That makes consistency a defensible default. A lifter does not need to reorganize a program around phase-based high- and low-volume blocks solely from the belief that one phase guarantees better muscle growth.

Preference remains legitimate. The authors noted that phase-based adjustments could be made according to individual preference, but were not necessary to achieve muscular adaptations in the trial. A preference-driven change should be judged by whether it helps the person train consistently and manage the workload, not presented as a proven hormonal optimization.

Program adjustments can stay ordinary: track performance, recovery, symptoms, and adherence; change a session when those observations warrant it; and avoid assuming the calendar predicts the same response every month. This is compatible with progressive training rather than a rejection of it. Our review of a progressive-overload trial provides a separate look at how training variables can be advanced without tying every change to a cycle phase.

The restrained practical choice is therefore simple: balanced training is an evidence-supported default, and phase-based changes can remain a preference rather than a requirement. If symptoms prompt changes, those changes should be understood as individualized autoregulation outside this trial's comparison—not as confirmation or rejection of its phase-volume result.